Breaking News, Promotions & Moves

Lilly Xu Named President of Shanghai ChemPartner

During her time in academia, Xu pioneered the use of human and animal hepatocytes in drug metabolism and drug-drug interactions.

ChemPartner has appointed Lilly Xu as the company’s president. Xu joined ChemPartner in 2017 to lead the strategic drug discovery services as senior vice president and head of DMPK and Exploratory Toxicology. Prior to joining ChemPartner, Dr. Xu held various positions with U.S. biotech and pharmaceutical companies including Amgen and Sanofi US. Xu was also the head of the Center for Predictive ADMET at Sanofi US. Xu earned a Ph.D. in molecular and cellular biology from Saint Louis Uni...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters